大雨
发表于 2025-3-27 00:19:09
Safe, Efficient Production of Retroviral Vectors,d with the retroviral vector (LASN) that contained the wild-type ADA gene. Results of this and a related ADA trial, which involved the introduction of the gene into CD34. cells from umbilical-cord blood obtained from neonates, have been published (B. et al. 1995; K. et al. 1995).
remission
发表于 2025-3-27 05:03:12
Clinical Systems for the Production of Cells and Tissues for Human Therapy,Second, transplantation procedures continue to be cost prohibitive for otherwise medically warranted applications. Third, the procurement of suitable tissues is often prohibitively invasive for the donor, in many cases requiring cadaveric material to be used. As a result, the full potential of transplantation therapies has not yet been realized.
Cholesterol
发表于 2025-3-27 09:18:37
Overview of Regulatory Expectations for Introducing Novel Therapies into Clinical Trials, referred to as the “case-by-case” approach. A combination of early dialogue, to identify the critical questions unique to an emerging technology, and a science-based rational approach, to answer these questions, has resulted not only in facilitation of clinical development, but in providing the appropriate data to support marketing applications.
碎石头
发表于 2025-3-27 09:53:12
http://reply.papertrans.cn/67/6685/668468/668468_34.png
渗透
发表于 2025-3-27 15:37:10
Formulation and Delivery of Nucleic Acids,ly into the affected tissues in vivo. One of the major challenges for the direct gene-transfer approach is to develop a vehicle that is able to protect the nucleic acids from degradation, while delivering the genes of interest to specific tissues and target-cell compartments.
植物群
发表于 2025-3-27 21:13:50
Book 1999 "The Biotech Revolution is Here". This article went on to say "New Genetic Technologies Will Transform Our Lives". These announcements were made many years after the first biotechnology companies, such as Genentech, Cetus, Amgen and Biogen, were formed-to commercialize the "New Biology". . At the t
Perennial长期的
发表于 2025-3-28 00:43:46
8楼
Acquired
发表于 2025-3-28 03:39:06
8楼
Antecedent
发表于 2025-3-28 06:54:02
8楼
发酵
发表于 2025-3-28 11:22:30
9楼